After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARVN belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Arvinas Inc is $813.73M. A total of 1.76 million shares were traded on the day, compared to an average of 2.43M shares.
In the most recent transaction, Loomis David K sold 230 shares of ARVN for 9.89 per share on Nov 07 ’25. After the transaction, the Chief Accounting Officer now owns 31,697 company shares. In a previous transaction on Sep 22 ’25, Morrison Briggs bought 30,000 shares at 7.57 per share. ARVN shares that Director owns now total 76,021.
Among the insiders who sold shares, Saik Andrew disposed of 5,700 shares on Jun 24 ’25 at a per-share price of $7.61. This resulted in the Chief Financial Officer holding 164,401 shares of ARVN after the transaction. In another insider transaction, Andrew Saik bought 5,927 shares at $7.35 per share on Jun 24 ’25.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARVN has a high of $26.78 and a low of $5.90.
As of this writing, ARVN has an earnings estimate of -$0.56 per share for the current quarter. EPS was calculated based on a consensus of 14.0 estimates, with a high estimate of $0.02 per share and a lower estimate of -$1.05. The company reported an EPS of -$0.63 in the last quarter
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARVN’s latest balance sheet shows that the firm has $1.50B in Cash & Short Term Investments as of fiscal 2021. There were $5.00M in debt and $261.70M in liabilities at the time. Its Book Value Per Share was $7.97, while its Total Shareholder’s Equity was $781.70M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARVN is Buy with a score of 3.80.
